Providence Therapeutics named Judyanna Yu, CPA, CA as CFO Wednesday morning.
Yu, who previously served as VP of corporate finance, operations and development at Cerecin, a biopharma company, is an industry veteran. She also served as CFO and COO of Re-Stem Biotech as well as CFO and VP of finance at several other companies throughout her career.
“I’m honored to join Providence’s forward-thinking leadership team in their mission to leverage their world-class mRNA platform toward the greatest possible clinical benefit for underserved people worldwide,” Yu said in a statement. “I look forward to supporting the company’s development as they advance toward late-stage vaccine trials while balancing their original focus on oncology programs.”
